National Center for Biotechnology Information

ncbi.nlm.nih.gov

The National Center for Biotechnology Information (NCBI) serves as an international resource for the scientific research community - providing access to public databases and software tools for analyzing biological data, as well as performing research in computational biology. The NCBI was established in 1988 by an act of the United States Congress as division of the National Library of Medicine at the National Institutes of Health, with a mission to find new approaches to deal with the increasing volume and complexity of biological data in order to facilitate the understanding of genes and their role in health and disease.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

THE BRACKEN ORGANIZATIONS MERGE TO CREATE A GLOBAL PLATFORM TO SUPPORT LIFE SCIENCE AND DIGITAL HEALTH TEAMS

The Bracken Group | October 11, 2021

news image

Three unique companies with shared origins have now united to better serve their clients in the life sciences industry. The new entity will be known as The Bracken Group (Bracken) with three divisions of the original three companies. The combined companies' mission continues to be supporting the success of companies that improve health, using an integrated network of clients, consultants, and employees across the globe. I am delighted to bring the ...

Read More

OPKO HEALTH ACQUIRES MODEX THERAPEUTICS, GAINS PROPRIETARY IMMUNOTHERAPY TECHNOLOGY WITH A FOCUS ON ONCOLOGY AND INFECTIOUS DISEASES

OPKO Health | May 10, 2022

news image

OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced the acquisition of ModeX Therapeutics, Inc. a privately held biotechnology company focused on developing innovative multi-specific immune therapies for cancer and infectious diseases. OPKO acquired ModeX for $300 million in OPKO common stock. Founded in October 2020 with headquarters in Natick, Mass., ModeX Therapeutics has developed highly flexible multi-specific antibody t...

Read More

Cell and Gene Therapy

CLEARMIND ANNOUNCES NOTICE OF PROPOSED STOCK CONSOLIDATION

Clearmind Medicine Inc. | September 26, 2022

news image

Clearmind Medicine Inc. a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, announces that it will be consolidating all of the issued and outstanding common shares of the Company on the basis of one (1) post consolidation Common Share for each thirty (30) pre consolidation Common Shares. The Corporation's board of directors set September 30, 2022 as the effective date of the Consolidation...

Read More

Industrial Impact

EMPATICA RECEIVES NEW FDA CLEARANCE FOR ITS HEALTH MONITORING PLATFORM AND ANNOUNCES SERIES B FINANCING

Empatica | November 23, 2022

news image

Empatica, a digital health and AI company developing medical-grade wearables and algorithms for health monitoring and diagnostics, today announced the clearance of its Empatica Health Monitoring Platform by the U.S. Food and Drug Administration. The Empatica Health Monitoring Platform is a full-stack remote health monitoring and data collection solution for research and healthcare professionals, built on data collected by Empatica's medical-grade, CE-certified EmbracePlus wear...

Read More
news image

Industrial Impact

THE BRACKEN ORGANIZATIONS MERGE TO CREATE A GLOBAL PLATFORM TO SUPPORT LIFE SCIENCE AND DIGITAL HEALTH TEAMS

The Bracken Group | October 11, 2021

Three unique companies with shared origins have now united to better serve their clients in the life sciences industry. The new entity will be known as The Bracken Group (Bracken) with three divisions of the original three companies. The combined companies' mission continues to be supporting the success of companies that improve health, using an integrated network of clients, consultants, and employees across the globe. I am delighted to bring the ...

Read More
news image

OPKO HEALTH ACQUIRES MODEX THERAPEUTICS, GAINS PROPRIETARY IMMUNOTHERAPY TECHNOLOGY WITH A FOCUS ON ONCOLOGY AND INFECTIOUS DISEASES

OPKO Health | May 10, 2022

OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced the acquisition of ModeX Therapeutics, Inc. a privately held biotechnology company focused on developing innovative multi-specific immune therapies for cancer and infectious diseases. OPKO acquired ModeX for $300 million in OPKO common stock. Founded in October 2020 with headquarters in Natick, Mass., ModeX Therapeutics has developed highly flexible multi-specific antibody t...

Read More
news image

Cell and Gene Therapy

CLEARMIND ANNOUNCES NOTICE OF PROPOSED STOCK CONSOLIDATION

Clearmind Medicine Inc. | September 26, 2022

Clearmind Medicine Inc. a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, announces that it will be consolidating all of the issued and outstanding common shares of the Company on the basis of one (1) post consolidation Common Share for each thirty (30) pre consolidation Common Shares. The Corporation's board of directors set September 30, 2022 as the effective date of the Consolidation...

Read More
news image

Industrial Impact

EMPATICA RECEIVES NEW FDA CLEARANCE FOR ITS HEALTH MONITORING PLATFORM AND ANNOUNCES SERIES B FINANCING

Empatica | November 23, 2022

Empatica, a digital health and AI company developing medical-grade wearables and algorithms for health monitoring and diagnostics, today announced the clearance of its Empatica Health Monitoring Platform by the U.S. Food and Drug Administration. The Empatica Health Monitoring Platform is a full-stack remote health monitoring and data collection solution for research and healthcare professionals, built on data collected by Empatica's medical-grade, CE-certified EmbracePlus wear...

Read More